Skandinaviska Enskilda Banken (SEB)
IMMU

Skandinaviska Enskilda Banken (SEB)’s Immunomedics Inc IMMU Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71,200
Closed -$6.05M – 1183
2020
Q3 		$6.05M Buy
71,200
+33,900
+91% +$1.71M 0.04% 299
2020
Q2 		$1.32M Buy
+37,300
New +$1.09M 0.01% 671

Skandinaviska Enskilda Banken (SEB)'s IMMU Position: Q4 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 71,200 shares — an estimated $6.05M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $6.05M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 71,200 Immunomedics Inc shares in Q4 2020, an estimated $6.05M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Immunomedics Inc position peaked at $6.05M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2020, filed 11 Feb 2021.